1. Home
  2. CLMB vs LCTX Comparison

CLMB vs LCTX Comparison

Compare CLMB & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$87.04

Market Cap

436.8M

Sector

Technology

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

366.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMB
LCTX
Founded
1982
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.8M
366.2M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
CLMB
LCTX
Price
$87.04
$1.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$136.00
$4.67
AVG Volume (30 Days)
54.9K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.77%
N/A
EPS Growth
14.29
25.00
EPS
4.64
N/A
Revenue
$652,517,000.00
$9,499,000.00
Revenue This Year
$2.60
$6.32
Revenue Next Year
$1.93
$124.49
P/E Ratio
$19.23
N/A
Revenue Growth
40.14
6.19
52 Week Low
$80.08
$0.37
52 Week High
$145.00
$2.09

Technical Indicators

Market Signals
Indicator
CLMB
LCTX
Relative Strength Index (RSI) 25.92 57.21
Support Level N/A $1.55
Resistance Level $112.37 $1.99
Average True Range (ATR) 6.98 0.10
MACD -3.34 0.02
Stochastic Oscillator 17.52 71.23

Price Performance

Historical Comparison
CLMB
LCTX

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: